Clarus_Patient Knowledge, Understanding & Behaviour Questionnaire

Consent Information

Patient Knowledge, Understanding & Behaviour Questionnaire

As requested by Health Canada on September 17, 2019, Mylan Pharmaceuticals ULC developed patient, prescriber and pharmacist Knowledge, Understanding and Behaviour Surveys for CLARUS® (Isotretinoin Capsules, USP) aimed at assessing the patients' and healthcare professionals' understanding of important risks (e.g., teratogenic, psychiatric, and other known risks) and effectiveness of birth control methods.

We invite you to complete the Knowledge, Understanding and Behaviour Survey for CLARUS® (Isotretinoin Capsules, USP)

*This question is required.

I have read and understand Viatris’ Privacy Notice.
Viatris Inc., its affiliates and subsidiaries (“Viatris”) may use the information collected above for the purpose of assessing patients’ and healthcare professionals’ understanding of important risks associated with Clarus and effectiveness of birth control methods. Some or all of this information may be shared with Health Canada. I understand and acknowledge that all information processed by Viatris is handled in accordance with local data protection laws and that it may be handled and processed in countries outside the jurisdiction in which it was collected. I understand that I can withdraw my consent at any time. Withdrawal of consent will not affect the legality of processing that took place before the withdrawal.

Select one that suits your description *This question is required.